Rhonda Bonilla, FNP-C
Rhonda Bonilla, MSN, FNP-BC, is a nationally certified Family Nurse Practitioner with over three decades of multifaceted experience spanning trauma and emergency care, immunology, dermatology, primary care, and health optimization. Her extensive background equips her with a deep and comprehensive understanding of the medical field.
After raising their family in Central California, Rhonda and her husband relocated to Southeastern Washington state, where she took on a pivotal role as Medical Director at Sculpt Wellness, a cutting-edge wellness facility. She has been instrumental in integrating advanced medical services, including hormone replacement therapy, testosterone replacement therapy (TRT), peptide therapy, and comprehensive weight loss program. Rhonda’s innovative approach and leadership have significantly elevated the standard of care at Sculpt, making it a premier destination for those seeking personalized wellness solutions.
Rhonda’s commitment to lifelong learning and professional growth drives her to stay at the forefront of medical advancements, with a current focus on peptides, GLP-1 receptor agonists, and other emerging anti-obesity treatments. Her dedication to understanding the intricate workings of the human body enables her to provide her clients with the highest level of care and informed guidance.
In addition to her professional achievements, Rhonda is a dedicated philanthropist, serving on the International Board of Directors for Heart to Honduras, a nonprofit organization focused on sustainable community development. She has also participated in numerous mission trips to Honduras, underscoring her deep commitment to global health and humanitarian efforts.
When not immersed in her work or volunteer activities, Rhonda enjoys traveling with her husband, particularly to tropical destinations, and cherishes time spent visiting their children in Texas and New York.
Session
The Science of GLP-1 RAs: Mechanisms of Action, Clinical Applications and Future Directions
Description
This presentation provides an in-depth exploration of GLP-1 receptor agonists (GLP-1 RAs), focusing on their mechanisms of action, clinical applications, benefits, and emerging research. GLP-1 RAs have garnered significant attention as a powerful tool in managing metabolic conditions, particularly type 2 diabetes and obesity. Through mimicking the effects of the endogenous hormone GLP-1, these drugs stimulate insulin secretion, inhibit glucagon release, and slow gastric emptying, promoting satiety and aiding in weight management.
We will delve into the mechanisms by which GLP-1 RAs interact with the body’s metabolic pathways, offering insights into how these agents can improve glycemic control and reduce cardiovascular risk. The presentation will highlight the clinical benefits and applications of GLP-1 RAs, with an emphasis on their expanding role in therapeutic strategies beyond diabetes, including obesity management and potential neuroprotective effects.
Attendees will gain a comprehensive understanding of the potential side effects associated with GLP-1 RAs, such as gastrointestinal symptoms, and will learn evidence-based strategies for managing these effects in clinical practice. Additionally, we will discuss the latest research on next-generation GLP-1 RAs and their implications for future treatment options, exploring ongoing studies that examine their effectiveness and safety in broader patient populations.
This session is ideal for healthcare professionals seeking to deepen their knowledge of GLP-1 RAs, optimize patient outcomes, and stay informed on the future directions of metabolic disease management.